Guardant Health issues $600M 1.25% convertible notes due 2031; retires $659.3M of 0% notes due 2027

Guardant Health, Inc.

Exchanged $600M new 1.25% convertible notes due 2031 for $659.3M of existing 0% notes due 2027.
After close, $490.7M of 2027 notes remain outstanding; new notes mature Feb 15, 2031.
Initial conversion price ~$62.22/share (35% premium to Feb 6 closing price).
Up to 13,017,960 shares may be issued upon conversion based on initial max conversion rate.
New notes are senior unsecured; interest payable semi-annually at 1.25%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.